106 related articles for article (PubMed ID: 1444753)
1. Epidermal growth factor receptor expression in Barrett's esophagus.
Poller DN; Steele RJ; Morrell K
Arch Pathol Lab Med; 1992 Nov; 116(11):1226-7. PubMed ID: 1444753
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor-alpha, epidermal growth factor receptor, and MiB-1 expression in Barrett's-associated neoplasia: correlation with prognosis.
Yacoub L; Goldman H; Odze RD
Mod Pathol; 1997 Feb; 10(2):105-12. PubMed ID: 9127315
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of epidermal growth factor receptors in Barrett's esophagus associated with alkaline reflux: a putative model for carcinogenesis.
Jankowski J; Hopwood D; Pringle R; Wormsley KG
Am J Gastroenterol; 1993 Mar; 88(3):402-8. PubMed ID: 8438848
[TBL] [Abstract][Full Text] [Related]
4. ErbB2 without erbB3 expression in metaplastic columnar epithelium of Barrett's esophagus.
Nishigaki H; Wada K; Tatsuguchi A; Sueoka N; Futagami S; Gudis K; Miyake K; Tsukui T; Sakamoto C
Digestion; 2004; 70(2):95-102. PubMed ID: 15375338
[TBL] [Abstract][Full Text] [Related]
5. Distribution of laminins in the basement membranes of the upper gastrointestinal tract and Barrett's oesophagus.
Dave U; Thursz MR; Ebrahim HY; Burke MM; Townsend ER; Walker MM
J Pathol; 2004 Mar; 202(3):299-304. PubMed ID: 14991894
[TBL] [Abstract][Full Text] [Related]
6. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
Levine DS; Rubin CE; Reid BJ; Haggitt RC
Lab Invest; 1989 Mar; 60(3):418-32. PubMed ID: 2927081
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical mucin expression of short-segment Barrett's esophagus.
Yamamoto S; Kijima H; Hara T; Kenmochi T; Kise Y; Tanaka H; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Tokai J Exp Clin Med; 2003 Jul; 28(2):57-63. PubMed ID: 14714830
[TBL] [Abstract][Full Text] [Related]
8. Mucin expression and proliferating cell index of esophageal Barrett's adenocarcinoma.
Yamamoto S; Kijima H; Hara T; Chino O; Shimada H; Tanaka M; Inokuchi S; Makuuchi H
Int J Mol Med; 2005 Sep; 16(3):375-80. PubMed ID: 16077942
[TBL] [Abstract][Full Text] [Related]
9. Gastrin induces proliferation in Barrett's metaplasia through activation of the CCK2 receptor.
Haigh CR; Attwood SE; Thompson DG; Jankowski JA; Kirton CM; Pritchard DM; Varro A; Dimaline R
Gastroenterology; 2003 Mar; 124(3):615-25. PubMed ID: 12612900
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression of decay-accelerating factor, a complement-regulatory protein, in the specialized intestinal metaplasia of Barrett's esophagus.
Hiraoka S; Mizuno M; Nasu J; Okazaki H; Makidono C; Okada H; Terada R; Yamamoto K; Fujita T; Shiratori Y
J Lab Clin Med; 2004 Apr; 143(4):201-6. PubMed ID: 15085078
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
12. Cytokeratin 7 and 20 expression in intestinal metaplasia of the distal oesophagus: relationship to gastro-oesophageal reflux disease.
Shearer C; Going J; Neilson L; Mackay C; Stuart RC
Histopathology; 2005 Sep; 47(3):268-75. PubMed ID: 16115227
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of Barrett's esophagus.
Chandrasoma P
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):270-8. PubMed ID: 9263345
[TBL] [Abstract][Full Text] [Related]
14. Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.
Kimchi ET; Posner MC; Park JO; Darga TE; Kocherginsky M; Karrison T; Hart J; Smith KD; Mezhir JJ; Weichselbaum RR; Khodarev NN
Cancer Res; 2005 Apr; 65(8):3146-54. PubMed ID: 15833844
[TBL] [Abstract][Full Text] [Related]
15. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage.
Amano Y; Ishihara S; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Miyake T; Miyaoka Y; Rumi MA; Ishimura N; Adachi K; Kinoshita Y
Aliment Pharmacol Ther; 2004 Oct; 20(7):793-802. PubMed ID: 15379840
[TBL] [Abstract][Full Text] [Related]
16. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
17. REG Ialpha protein expression in Barrett's esophagus.
Chinuki D; Amano Y; Ishihara S; Moriyama N; Ishimura N; Kazumori H; Kadowaki Y; Takasawa S; Okamoto H; Kinoshita Y
J Gastroenterol Hepatol; 2008 Feb; 23(2):296-302. PubMed ID: 18289358
[TBL] [Abstract][Full Text] [Related]
18. Abundant expression of the intestinal protein villin in Barrett's metaplasia and esophageal adenocarcinomas.
Regalado SP; Nambu Y; Iannettoni MD; Orringer MB; Beer DG
Mol Carcinog; 1998 Jul; 22(3):182-9. PubMed ID: 9688144
[TBL] [Abstract][Full Text] [Related]
19. Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients.
Yagi K; Nakamura A; Sekine A
J Gastroenterol Hepatol; 2005 Jun; 20(6):929-34. PubMed ID: 15946143
[TBL] [Abstract][Full Text] [Related]
20. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
El-Zimaity HM; Graham DY
Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
